BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 26111272)

  • 1. Intratumoral CD8+ Lymphocyte Infiltration as a Prognostic Factor and Its Relationship With Cyclooxygenase 2 Expression and Microsatellite Instability in Endometrial Cancer.
    Suemori T; Susumu N; Iwata T; Banno K; Yamagami W; Hirasawa A; Sugano K; Matsumoto E; Aoki D
    Int J Gynecol Cancer; 2015 Sep; 25(7):1165-72. PubMed ID: 26111272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A template to quantify the location and density of CD3 + and CD8 + tumor-infiltrating lymphocytes in colon cancer by digital pathology on whole slides for an objective, standardized immune score assessment.
    Lea D; Watson M; Skaland I; Hagland HR; Lillesand M; Gudlaugsson E; Søreide K
    Cancer Immunol Immunother; 2021 Jul; 70(7):2049-2057. PubMed ID: 33439293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymerase ε (POLE) ultra-mutation in uterine tumors correlates with T lymphocyte infiltration and increased resistance to platinum-based chemotherapy in vitro.
    Bellone S; Bignotti E; Lonardi S; Ferrari F; Centritto F; Masserdotti A; Pettinella F; Black J; Menderes G; Altwerger G; Hui P; Lopez S; de Haydu C; Bonazzoli E; Predolini F; Zammataro L; Cocco E; Ferrari F; Ravaggi A; Romani C; Facchetti F; Sartori E; Odicino FE; Silasi DA; Litkouhi B; Ratner E; Azodi M; Schwartz PE; Santin AD
    Gynecol Oncol; 2017 Jan; 144(1):146-152. PubMed ID: 27894751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leukocyte infiltrate in gastrointestinal adenocarcinomas is strongly associated with tumor microsatellite instability but not with tumor immunogenicity.
    Bernal M; Concha A; Sáenz-López P; Rodríguez AI; Cabrera T; Garrido F; Ruiz-Cabello F
    Cancer Immunol Immunother; 2011 Jun; 60(6):869-82. PubMed ID: 21400022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lower cyclooxygenase-2 expression is associated with recurrence of solitary non-muscle invasive bladder carcinoma.
    Tadin T; Krpina K; Stifter S; Babarović E; Fučkar Z; Jonjić N
    Diagn Pathol; 2012 Nov; 7():152. PubMed ID: 23126361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-plex spatial transcriptomic profiling reveals distinct immune components and the HLA class I/DNMT3A/CD8 modulatory axis in mismatch repair-deficient endometrial cancer.
    Guo J; Tang B; Fu J; Zhu X; Xie W; Wang N; Ding Z; Song Z; Yang Y; Xu G; Xiao X
    Cell Oncol (Dordr); 2024 Apr; 47(2):573-585. PubMed ID: 37847338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MSI-H colorectal cancers preferentially retain and expand intraepithelial lymphocytes rather than peripherally derived CD8+ T cells.
    Baker K; Foulkes WD; Jass JR
    Cancer Immunol Immunother; 2009 Jan; 58(1):135-44. PubMed ID: 18488217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of immune infiltration signatures on prognosis in endometrial carcinoma is dependent on the underlying molecular subtype.
    Dessources K; Ferrando L; Zhou QC; Iasonos A; Abu-Rustum NR; Reis-Filho JS; Riaz N; Zamarin D; Weigelt B
    Gynecol Oncol; 2023 Apr; 171():15-22. PubMed ID: 36804617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploration of the relationship between tumor-infiltrating lymphocyte score and histological grade in breast cancer.
    Kang D; Wang C; Han Z; Zheng L; Guo W; Fu F; Qiu L; Han X; He J; Li L; Chen J
    BMC Cancer; 2024 Mar; 24(1):318. PubMed ID: 38454386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Checkpoint inhibitors in endometrial cancer: preclinical rationale and clinical activity.
    Mittica G; Ghisoni E; Giannone G; Aglietta M; Genta S; Valabrega G
    Oncotarget; 2017 Oct; 8(52):90532-90544. PubMed ID: 29163851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of tumor budding, desmoplastic reaction, and lymphocytic infiltration in patients with gastric adenocarcinoma.
    Yavuz A; Simsek K; Alpsoy A; Altunay B; Gedik EO; Unal B; Bassorgun CI; Tatli AM; Elpek GO
    World J Gastrointest Pathophysiol; 2024 Apr; 15(1):91237. PubMed ID: 38682027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MUC16 mutations improve patients' prognosis by enhancing the infiltration and antitumor immunity of cytotoxic T lymphocytes in the endometrial cancer microenvironment.
    Hu J; Sun J
    Oncoimmunology; 2018; 7(10):e1487914. PubMed ID: 30288353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Polymerase e-Mutated and Microsatellite-Instable Endometrial Cancers With Neoantigen Load, Number of Tumor-Infiltrating Lymphocytes, and Expression of PD-1 and PD-L1.
    Howitt BE; Shukla SA; Sholl LM; Ritterhouse LL; Watkins JC; Rodig S; Stover E; Strickland KC; D'Andrea AD; Wu CJ; Matulonis UA; Konstantinopoulos PA
    JAMA Oncol; 2015 Dec; 1(9):1319-23. PubMed ID: 26181000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing the prognostic role of ATR mutation in endometrioid endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study.
    Zighelboim I; Ali S; Lankes HA; Backes F; Moore K; Mutch D; Robison K; Behbakht K; Waggoner S; Ghebre RG; Pearl M; Ramirez NC; Goodfellow P
    Gynecol Oncol; 2015 Sep; 138(3):614-9. PubMed ID: 26144601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Significance of MLH1 Methylation and CpG Island Methylator Phenotype as Prognostic Markers in Patients with Gastric Cancer.
    Shigeyasu K; Nagasaka T; Mori Y; Yokomichi N; Kawai T; Fuji T; Kimura K; Umeda Y; Kagawa S; Goel A; Fujiwara T
    PLoS One; 2015; 10(6):e0130409. PubMed ID: 26121593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a Metabolism-Related Signature for the Prediction of Survival in Endometrial Cancer Patients.
    Fan Y; Li X; Tian L; Wang J
    Front Oncol; 2021; 11():630905. PubMed ID: 33763366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of an immune signature for prognosis and immunotherapy response in endometrial cancer.
    Meng Y; Yang Y; Zhang Y; Yang X; Li X; Hu C
    Am J Transl Res; 2021; 13(2):532-548. PubMed ID: 33594308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive Analysis of ESRRA in Endometrial Cancer.
    Wang S; Huo X
    Technol Cancer Res Treat; 2021; 20():1533033821992083. PubMed ID: 33525981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of TICRR and PPIF confer poor prognosis in endometrial cancer identified by gene co-expression network analysis.
    Yang L; Cui Y; Sun X; Wang Y
    Aging (Albany NY); 2021 Jan; 13(3):4564-4589. PubMed ID: 33495413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DACH1 mutation frequency in endometrial cancer is associated with high tumor mutation burden.
    Riggs MJ; Lin N; Wang C; Piecoro DW; Miller RW; Hampton OA; Rao M; Ueland FR; Kolesar JM
    PLoS One; 2020; 15(12):e0244558. PubMed ID: 33378353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.